tirzepatide menopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 New study links combination of

Clinical trials have demonstrated that tirzepatide can reduce hemoglobin A1c by up to 2.5% in type 2 diabetes, with weight loss typically ranging from 5-10% in diabetes patients and 15-20% in those treated specifically for obesity

It is unclear if Melanotan II can increase (or reduce) the risk of developing melanoma, because reports of melanomas associated with its use have coincided with heavy UV exposure and sun bed use

Using semaglutide after its expiration date poses several potential safety concerns that patients and healthcare providers should carefully consider

Understanding Ozempic Ozempic is an FDA-approved prescription medication used to treat type 2 diabetes

This guide addresses semaglutide specifically from a male perspective, covering what the research shows about results in men, how weight loss affects testosterone and other male-specific health concerns, and practical considerations for men starting treatment